Latest Headlines

Latest Headlines

South Korean startup biotechs gain government, banking funding lift

New life science firms hoping to get off the ground in South Korea will be able to receive extra funding help as the government announces plans to boost more startups in the region.

Microsoft co-founder Paul Allen launches $100M bioscience fund

The Paul G. Allen Frontiers Group has officially launched today as the life sciences funding arm of the Allen Institute. The Group, headquartered in Seattle, WA, has been set up by the multi-millionaire Microsoft co-founder. 

Quintiles, Mitsui and investors pay toward a new $866M development fund

The world's biggest CRO Quintiles and a number of international investors have come together to create a new fund aimed at lightening the cost burden of pharma drug development.

Janssen adds COPD and diabetes to its venture portfolio for preventative medicine

Janssen has signed up two more therapy areas to its unique Disease Interception Accelerator (DIA) program as it continues to look for future growth and deals from new places.

NHS launches digital health tech accelerator in London

The U.K.'s National Health Service doesn't have the reputation of being particularly technology savvy. In fact, it's had a long and public struggle--that's not yet complete--to get electronic medical records into place.

Boehringer Ingelheim, Propeller Health to enroll 2,500 'smart' inhaler patients in evidence-generation program

Big Pharma and Boehringer Ingelheim are expanding their "smart inhaler" partnership with Madison, WI's Propeller Health. Respimat patients will have the opportunity to enroll in a program offered at select U.S. medical centers that's designed to determine how smart inhaler tolls affect adherence rates and patient engagement, the companies said in a release.

Zhejiang Medicine at work with Ambrx on PhI breast cancer candidate

Hangzhou-based Zhejiang Medicine, or ZMC, has started Phase I work in Australia and New Zealand on an antibody candidate targeting HER2-positive breast cancer with San Diego-based Ambrx, building on a 2013 partnership.

NovAliX signs EM-based analysis deal with FEI

French CRO NovAliX has penned a new partnership with microscopy specialist FEI as it looks to broaden its offering to biopharma clients.

CANbridge in potential $134M licensing deal with AVEO Oncology drug

Beijing-based CANbridge Life Sciences has built on its aim to expand licensing opportunities with a potential $134 million deal with Nasdaq-listed Aveo Oncology for a clinical-stage ErbB3 (HER3) antibody candidate AV203.

GE Healthcare to add startup's CT lung density analysis to its new 'Health Cloud'

Late last year, GE Healthcare announced that it would be taking its imaging data and analysis to the cloud. It's now revealed one of the first software applications that will be available via the GE Health Cloud: an automated, biomarker-based quantitative lung imaging analysis from Minneapolis startup Imbio.